AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇨🇮
IOPROMIDE in Côte d'Ivoire
4 products registered with AIRP — 0 active, 4 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ULTRAVIST 300MG/ 100 ML SOLUTION AQUEUSE POUR INJECTABLEION FLACON DE 100ML | E-2015-529 | BAYER WEST & CENTRAL AFRICA | expired | 13 Jan 2026 |
| ULTRAVIST-370 370MG SOLUTION INJECTABLE IV FLACON DE 100ML | E-2015-531 | BAYER WEST & CENTRAL AFRICA | expired | 13 Jan 2026 |
| ULTRAVIST-370 370MG SOLUTION INJECTABLE IV FLACON DE 50ML | E-2015-530 | BAYER WEST & CENTRAL AFRICA | expired | 13 Jan 2026 |
| ULTRAVIST-300 300MG SOLUTION INJECTABLE IV FLACON DE 50ML | E-2015-528 | BAYER WEST & CENTRAL AFRICA | expired | 13 Jan 2021 |
IOPROMIDE — AIRP Registration Details
AIRP (Côte d'Ivoire) has 4 registered products containing IOPROMIDE, of which 0 are currently active. Data is sourced directly from the official AIRP drug register and refreshed daily.
Track IOPROMIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.